BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32876021)

  • 21. Sentinel lymph node biopsy in cutaneous melanoma of the head and neck using the indocyanine green SPY Elite system.
    Vahabzadeh-Hagh AM; Blackwell KE; Abemayor E; St John MA
    Am J Otolaryngol; 2018; 39(5):485-488. PubMed ID: 29803536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
    Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
    Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'.
    Gyorki DE; Barbour A; Hanikeri M; Mar V; Sandhu S; Thompson JF
    Australas J Dermatol; 2017 Nov; 58(4):274-277. PubMed ID: 28718222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sentinel Lymph Nodes in Cutaneous Melanoma.
    Prieto VG
    Clin Lab Med; 2017 Sep; 37(3):417-430. PubMed ID: 28802493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel Lymph Node Biopsy for Cutaneous Head and Neck Melanoma: Mapping the Parotid Gland.
    Picon AI; Coit DG; Shaha AR; Brady MS; Boyle JO; Singh BB; Wong RJ; Busam KJ; Shah JP; Kraus DH
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):9001-9009. PubMed ID: 16715435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of sentinel lymph node biopsy as a staging procedure in patients with melanoma: A critical appraisal.
    Nieweg OE; Cooper A; Thompson JF
    Australas J Dermatol; 2017 Nov; 58(4):268-273. PubMed ID: 28707391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sentinel node biopsy for malignant melanoma. Technical details and clinical results on 390 patients].
    Caggiati A; Migliano E; Potenza C; Gabrielli F; Tartaglione G; Pacchiarotti A; Ruatti P; Puddu P
    Minerva Chir; 2002 Aug; 57(4):481-7. PubMed ID: 12145579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of level II and III axillary nodes metastases in patients with positive sentinel lymph nodes in melanoma: a multi-institutional study in Japan.
    Tsutsumida A; Takahashi A; Namikawa K; Yamazaki N; Uhara H; Teramoto Y; Takenouchi T; Fukushima S; Yokota K; Uehara J; Matsushita S; Shibayama Y; Hatta N; Masui Y; Uchi H; Fujisawa Y; Ogata D
    Int J Clin Oncol; 2016 Aug; 21(4):796-800. PubMed ID: 26759315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.
    Oude Ophuis CM; Verhoef C; Rutkowski P; Powell BW; van der Hage JA; van Leeuwen PA; Voit CA; Testori A; Robert C; Hoekstra HJ; Grünhagen DJ; Eggermont AM; van Akkooi AC
    Eur J Surg Oncol; 2016 Dec; 42(12):1906-1913. PubMed ID: 27266406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: Reliability of the procedure and analysis of failures after long-term follow-up.
    Jacobs IA; Chevinsky AH; Swayne LC; Magidson JG; Britto EJ; Smith TJ
    J Surg Oncol; 2001 Jul; 77(3):157-64. PubMed ID: 11455551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphoscintigraphy and sentinel lymph node biopsy, in cutaneous melanoma staging and treatment decisions.
    Jaukovic L; Sijan G; Rajović M; Kandolf-Sekulovic L; Radulovic M; Mijuskovic Z; Zolotarevski L; Ajdinovic B; Novakovic M
    Hell J Nucl Med; 2015; 18(2):146-51. PubMed ID: 26187215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.
    Gipponi M; Di Somma C; Peressini A; Solari N; Gliori S; Nicolo G; Schenone F; Queirolo P; Sertoli MR; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):133-40. PubMed ID: 14991885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.
    Mraz-Gernhard S; Sagebiel RW; Kashani-Sabet M; Miller JR; Leong SP
    Arch Dermatol; 1998 Aug; 134(8):983-7. PubMed ID: 9722728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency and implications of occipital and posterior auricular sentinel lymph nodes in scalp melanoma.
    Carmichael H; King BBT; Friedman C; Torphy RJ; Medina T; Gleisner A; McCarter MD; Kwak JJ; Kounalakis N
    J Surg Oncol; 2019 Dec; 120(8):1470-1475. PubMed ID: 31614003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transected thin melanoma: Implications for sentinel lymph node staging.
    Herbert G; Karakousis GC; Bartlett EK; Zaheer S; Graham D; Czerniecki BJ; Fraker DL; Ariyan C; Coit DG; Brady MS
    J Surg Oncol; 2018 Mar; 117(4):567-571. PubMed ID: 29194673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validity of ultrasound-guided aspiration needle biopsy in the diagnosis of micrometastases in sentinel lymph nodes in patients with cutaneous melanoma.
    Šijan G; Kozarski J; Stepić N; Milojević S; Stefanović D; Tatomirović Ž; Jauković L; Vesanović S; Rajović M
    Vojnosanit Pregl; 2016 Oct; 73(10):934-40. PubMed ID: 29328105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinico-pathological features of patients with melanoma and positive sentinel lymph node biopsy: a single institution experience.
    Homolak D; Šitum M; Čupić H
    Acta Dermatovenerol Croat; 2015; 23(2):122-9. PubMed ID: 26228823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression and Sentinel Lymph Node Status in Melanoma Progression.
    Letca AF; Ungureanu L; Şenilă SC; Grigore LE; Pop Ş; Fechete O; Vesa ŞC; Cosgarea R
    Med Sci Monit; 2018 Mar; 24():1359-1365. PubMed ID: 29507279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interval nodes: the forgotten sentinel nodes in patients with melanoma.
    Uren RF; Howman-Giles R; Thompson JF; McCarthy WH; Quinn MJ; Roberts JM; Shaw HM
    Arch Surg; 2000 Oct; 135(10):1168-72. PubMed ID: 11030873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.